Today’s AI Top Pick: TMDX

7/29/2026 · Highly Shorted Deep Rotation RSI & Conf screen · a free sample of K3vl4r’s AI-curated picks.

AI-ranked from a screened shortlist, with entry strategy, targets, and risks.

View the live TMDX price forecast →

Today's pick · Highly Shorted Deep Rotation RSI & ConfTMDXBUY NOW8.7 / 107/29/2026

TransMedics (TMDX) is the cleanest setup on the board today: strong fundamentals, deep-value weekly positioning, and unusually rare multi-timeframe forecast alignment. Fundamentally, TMDX carries a PE of 17.51 with ROE of 45.22, a profit margin of 27.04%, sales growth of 30.24% YoY, EPS growth next-year estimate of 72.69%, analyst recom of 1.64 and target upside of +48% — one of the few names in this pool with both real profitability AND real growth (fundamental_score 6.75, bullish_prob 1.0, near_term_bullish 1.0). The tape agrees. On the 1h, 4h and 1d timeframes, ALL three forecast horizons are positive and materially so: 1h fc +23.8%/+24.65%/+29.68%, 4h +36.13%/+29.69%/+32.11%, and 1d +24.72%/+51.51%/+46.66%. That's short/mid/long agreement across three timeframes — a level of coherence you rarely get. The 1wk is flat (short -3.79%, mid -1.26%, long +0.43%) but crucially not bearish, and the weekly dd_from_21bar_high of -38.05% with position 22.06% means you are buying deep into a corrected weekly base, NOT chasing a top. Compare that to WIX or EPAM, which have similarly big forecasts but sit at pos_in_21bar_range 97–100% on daily — those are extended. News flow supports rather than undermines the thesis: ChartMill flagged TMDX (7/28) as 'an affordable growth stock with strong earnings momentum,' and Evercore ISI maintains Outperform (though they trimmed the target to $90 on 7/6). No dilution, no legal overhang, no short-seller report — a rare cleanliness in a screen that by definition selects names with >15% short float (TMDX shortFloat is 23.23%, so a squeeze setup is embedded). Why today rather than wait? The 1h/4h forecasts are the highest-conviction near-term positives in the pool (+23–36% short-term), and TMDX is at only 22% of its weekly range with RSI 56.64 — plenty of room. Waiting risks paying up if the 1h fc +23.8% starts to unfold. CELH has an equally deep base but its short-term forecasts are mixed (4h short -10.1%), and WIX has better forecasts but is already pinned at the top of its daily range.

TMDX forecast chart
Entry zone
$75.50 - $77.50 (current $76.50; scale in on any intraday dip toward $75)
Stop loss
$69.50 (below the recent weekly base low, ~-9%; a break there invalidates the deep-value setup)
First target
$88 - $90 (Evercore's revised target and roughly the 1h/4h forecast band of +23–36%)
Longer target
$110 - $115 (aligned with 1d mid/long forecasts of +46–51% and consistent with a partial retrace of the 38% weekly drawdown)
Risks
  • Weekly forecast is essentially flat (fc_short -3.79%, fc_mid -1.26%, fc_long +0.43%) — the higher-timeframe trend has not yet turned up, so this is a mean-reversion trade, not a breakout
  • Short float of 23.23% cuts both ways — a positive catalyst can squeeze, but negative organ-transport headlines have historically produced -20% single-day drops
  • Evercore trimmed the price target to $90 on 7/6 and analyst target cuts have been a recurring theme; another cut into earnings could cap upside
  • Debt/Equity of 1.75 is elevated for a med-tech and makes the name sensitive to any credit tightening
  • Position size should respect the 21-bar weekly high being 38% away — full retracement is not the base case; consider trimming into the $88–90 zone
Honorable mentions
CELHBest fundamentals in the pool (fund_score 7.5, sales +123% YoY, target upside +90.2%, recom 1.36) and deepest weekly base (pos 12.89%, dd -34.1%). 1d forecasts are massive (+24.57/+52.96/+45.95) and near_term_bullish is 1.0. Slight demotion vs TMDX because 4h short forecast is -10.1% and headlines include 'Out-of-Favor Stocks That Fall Short' — a solid BUY_PULLBACK toward $28.
WIXThe most bullish forecast profile in the pool — every single horizon on every timeframe is positive, with 1d fc_long +74.17% and 1wk fc_long +107.35%. Downgraded from #1 because it sits at pos_in_21bar_range 98.1% on daily (extended) and fundamentals are thinner (negative profit margin, no PE). Great swing candidate on a pullback to $54–55.
Full ranking (30)
#SymbolVerdictScoreRead
1TMDXBUY NOW8.7Elite fundamentals (ROE 45, PM 27, sales +30%) + all three intraday TFs green + weekly pos 22% = deep-value entry with confirmed tape.
2CELHBUY NOW8.2Best fundamental score (7.5) with 1d fc +52%/+45% and weekly pos 12.89% — near-term_bullish 1.0, ideal deep-rotation setup.
3WIXBUY PULLBACK7.8Every forecast positive across every TF (1wk long +107%), but pos 98% on daily — wait for $54 or scale in small.
4EPAMBUY PULLBACK7.4PE 14.4/fwdPe 7.07, 4h fc_long +78%, positive OpenAI news, but daily pos 97.58% — buy the dip.
5KVYOBUY NOW6.71d fc +22.76% long, Citi target raise to $34, recom 1.17, near_term 0.6 — clean growth-software setup.
6NCNOBUY NOW6.5Multi-TF alignment on daily/weekly (+15%/+30% long), near_term 0.8, 'Cracks the Rule of 40' Seeking Alpha piece.
7QDELBUY PULLBACK6.31d fc +41% long and 1wk +46.79%, position 27.93% (deep base), but negative profit margin -45.55% is a landmine.
8OWLBUY NOW6.21d fc +37.49% long, near_term 0.6, but PE 119 and profit margin only 2.96% cap conviction.
9CLVTBUY PULLBACK6.01wk fc_long +170.96% and deep weekly pos 18.61%, but negative margins and leverage overhang from Seeking Alpha.
10PGYWAIT5.7Best fundamental_score (8) with PEG 0.19 and target upside +59.8%, but 1h/4h forecasts negative and pos 21% on daily = broken short-term tape.
11UPWKBUY NOW5.51d fc +55% mid/+53% long, PEG 0.43, profit margin 13.81%, weekly pos 33.89% — coiled setup.
12FOURWAIT5.3PEG 0.54 and fwdPe 8.08 attractive, but 1h fc_long -15.13% and pos 99.5% on daily — extended entry.
13DXCBUY PULLBACK5.11wk fc_mid +60% and near_term 0.8, ElevenLabs AI partnership, but PE 185 and thin margins limit size.
14KDBUY PULLBACK5.01d fc_long +79.93%, PEG 0.22, but 'Reduce' consensus rating and target upside only 1.9% cap it.
15WHRBUY PULLBACK4.71wk fc_long +148.95% and weekly pos 6.58% (deep base), Tepper adding, but recom 3.15 and 1h flat.
16ITWAIT4.61wk fc_long +109%, ROE 94.87%, but daily pos 98.78% and near_term_bullish 0.0 — chasing risk.
17MNDYWAIT4.41wk fc_long +122% is enormous but near_term 0.2 and 20% layoffs headline are red flags.
18PPCWAIT4.3PE 8, ROE 25.9, but 1h/1wk forecasts negative and Q2 print looming next week.
19NXTCAVOID4.0Merger with Avere and CVR structure — 'stock' effectively liquidating; forecasts irrelevant.
20TTANWAIT3.91h/4h forecasts all negative (-19/-16/-12), CFO insider selling, negative margins.
21PTLOAVOID3.71wk fc_long -33.16%, 'Risky' StockStory piece, weekly pos 27.89% with negative momentum.
22DFHWAIT3.6PE 9.68 cheap, but near_term 0.2, 1h fc_long -7.57%, sales -8.5% YoY.
23ARDTAVOID3.3All forecast horizons negative on 1h/4h/1d, RSI 72.71 (overbought), bullish_prob 0 — broken.
24DUOLAVOID3.2targetUpsidePct -18.4% (analysts see downside), 1d/4h all forecasts negative, near_term_bullish 0.0.
25GPGIAVOID3.0SalesYoY -100%, 1h fc_long -40.75%, 1wk fc_long -40.82% — screen artifact.
26LRNAVOID2.8All four timeframes show negative forecasts (-11/-17/-3/-2 short), bullish_prob only 0.2 despite good fundamentals — trend has rolled.
27VIAAVOID2.71h fc_long -33.59%, 4h -14%, bullish_prob null, profit margin -21.63% — no thesis.
28KLARAVOID2.5All TFs negative forecasts, bullish_prob null, and Apple/iPhone leasing news is priced in.
29ASANAVOID2.3ROE -87.55%, shortFloat 39.51%, negative margins — screen inclusion is technical, not investable.
30CNXCAVOID2.0'Shares Getting Obliterated' headline 7/23, negative ROE -37.73, profit margin -13.17% — broken.

Get AI top picks & forecasts on any stock

K3vl4r screens the market daily and ranks the best setups with AI — forecasts, scored fundamentals & technicals, and multi-horizon price targets. Create a free account to explore them all.

Create your free account →

Already a member? Sign in · Join our Discord

⚠️ This AI-generated analysis is for informational purposes only and is not financial advice. Forecasts and scores are model outputs that can be wrong; markets involve substantial risk of loss. Do your own research.